On the recordJuly 11, 2017
It is past time for Congress to act, and as FDA's authorizing committee it is our job to clarify the statute.
Source
congress.govGreg Walden: “It is past time for Congress to act, and as FDA's authorizing committee it is our job to clarify the statute.”
Editor's note · Context
Walden emphasizes the need for Congress to clarify FDA regulations on off-label drug communications.
Share
More from Greg Walden
Dec 9, 2020
I don't believe I have any other speakers on my side of the aisle on this measure. I urge its passage, and I yield back the balance of my time.
Dec 9, 2020
It is a great privilege now to recognize the gentleman from Kentucky (Mr. Guthrie), who is the top Republican on the Oversight and Investigations Subcommittee and has really done incredible work as we put together our package on Operation…
May 11, 2021
I want to make sure that it is a responsible way for all parties, which is why a number of us are very concerned about the administration's recent support of the waiver to release and transfer the IP for the vaccine.
Mar 10, 2023
The FCC Process Reform Act is bipartisan legislation that passed the House on March 11 of this year and would bring needed reforms to the commission's processes.
Other voices in this conversation
